During the past decade, Shonan Atsugi Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shonan Atsugi Hospital" #1 collaborator was "NPO International TRI Network" with 2 trials as a collaborator and "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Shonan Atsugi Hospital" are "Acute Myocardial Infarction" (1 trials), "Alzheimer's Disease" (1 trials) and "Patency of the Radial Artery" (1 trials). Many other conditions were trialed in "Shonan Atsugi Hospital" in a lesser frequency.

Most popular intervention types in "Shonan Atsugi Hospital" are "Procedure" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "ACC-001" (1 trials), "Biolimus A9 eluting stents" (1 trials), "PCI (percutaneous coronary intervention)" (1 trials) and "uncoated stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shonan Atsugi Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Shonan Atsugi Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Shonan Atsugi Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Shonan Atsugi Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".